GM-CSF Promotes the Development of Dysfunctional Vascular Networks in Moyamoya Disease
- 19 December 2023
- journal article
- research article
- Published by Springer Nature in Neuroscience Bulletin
- Vol. 40 (4) , 451-465
Abstract
Moyamoya disease (MMD) is a chronic occlusive cerebrovascular disease with the development of a network of abnormal vessels. Immune inflammation is associated with the occurrence and development of MMD. However, the mechanisms underlying the formation of the abnormal vascular network remain unclear. Twenty-eight patients with MMD, 26 ischemic stroke patients, and 26 unrelated healthy volunteers were enrolled in this study The data showed that the levels of granulocyte-macrophage colony-stimulating factor (GM-CSF) were higher in MMD patients than in healthy controls (P <0.01), and GM-CSF was mainly from Th1 and Th17 cells in MMD. We found that increased GM-CSF drove monocytes to secrete a series of cytokines associated with angiogenesis, inflammation, and chemotaxis. In summary, our findings demonstrate for the first time the important involvement of GM-CSF in MMD and that GM-CSF is an important factor in the formation of abnormal vascular networks in MMD.Keywords
This publication has 43 references indexed in Scilit:
- Guidelines for the Early Management of Patients With Acute Ischemic StrokeStroke, 2013
- Clinical and Immunopathological Features of Moyamoya DiseasePLOS ONE, 2012
- Hypoxia-Inducible Factor-2α Regulates GM-CSF–Derived Soluble Vascular Endothelial Growth Factor Receptor 1 Production from Macrophages and Inhibits Tumor Growth and AngiogenesisThe Journal of Immunology, 2011
- Identification of RNF213 as a Susceptibility Gene for Moyamoya Disease and Its Possible Role in Vascular DevelopmentPLOS ONE, 2011
- Opposing roles for HIF-1α and HIF-2α in the regulation of angiogenesis by mononuclear phagocytesBlood, 2011
- Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2009
- GM-CSF regulates intimal cell proliferation in nascent atherosclerotic lesionsJournal of Experimental Medicine, 2009
- In vivo activation of JAK2/STAT‐3 pathway during angiogenesis induced by GM‐CSFThe FASEB Journal, 2001
- Angiogenic Factors in Moyamoya DiseaseStroke, 1996
- Smooth muscle cell proliferation and localization of macrophages and T cells in the occlusive intracranial major arteries in moyamoya disease.Stroke, 1993